Principal, Venture Investments
Anurag Mehta joined Johnson & Johnson Innovation - JJDC, Inc. (JJDC) in 2020 and focuses on investments in Consumer Healthcare sector. Based in New York City, Anurag is responsible for initiating and managing equity investments to drive business innovation and deliver new and sustainable business models for Johnson & Johnson’s Consumer Health Division.
Prior to JJDC, Anurag spent over four years as the Global Head of Strategic Transactions within the Consumer Health Business Development team at J&J where he led acquisitions, equity investments, and other strategic transactions. During his tenure in the group, he was involved in a number of key Consumer acquisitions, including the acquisition of the Dr Ci:Labo brand in 2018 and OGX brand in 2016. In 2019, Anurag additionally acted as the Interim Head of JLABS@NYC, an important expansion of Johnson & Johnson Innovation. Prior to J&J, he spent almost a decade in the Mergers & Acquisitions Group within the Investment Banking Division at Credit Suisse in New York where he advised on over $60 billion of announced acquisitions, divestitures, JVs, corporate restructurings and takeover defense transactions across various industry verticals. Anurag started his career in Product Development at Oracle Corporation in their Advanced Supply Chain Planning Division in Redwood Shores, California where he was responsible for designing and developing algorithms for supply chain scheduling.
Anurag holds an MBA from the University of Chicago Booth School of Business, an MS in Industrial Engineering & Operations Research from the University of Florida, and a B.Tech. in Mechanical Engineering from the Indian Institute of Technology, New Delhi.